Literature DB >> 10829910

Enzyme studies in GM2 gangliosidiosis, and their application in prenatal diagnosis.

M Kaur1, I C Verma.   

Abstract

Assay of hexosaminidase A and B enzymes in four cases with developmental regression and cherry red spot on fundus examination confirmed that three cases had Tay-Sachs disease, and one case had Sandhoff disease. Prenatal diagnosis was carried out by hexosaminidase enzyme assay in amniotic fluid and cells in one family, and chorionic villus sample in the second family. The fetus was diagnosed to be unaffected in one, and affected in the other family. Assay of hexosaminidase A and B is useful for specific diagnosis of GM2 gangliosidosis, and for prenatal diagnosis to reduce the burden of these disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10829910     DOI: 10.1007/bf02755072

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  7 in total

1.  Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase.

Authors:  D H LEABACK; P G WALKER
Journal:  Biochem J       Date:  1961-01       Impact factor: 3.857

2.  Mutation in GM2-gangliosidosis B1 variant.

Authors:  K Ohno; K Suzuki
Journal:  J Neurochem       Date:  1988-01       Impact factor: 5.372

3.  Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase.

Authors:  B H Paw; S M Moskowitz; N Uhrhammer; N Wright; M M Kaback; E F Neufeld
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

4.  Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.

Authors:  M Kaback; J Lim-Steele; D Dabholkar; D Brown; N Levy; K Zeiger
Journal:  JAMA       Date:  1993-11-17       Impact factor: 56.272

5.  Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.

Authors:  B H Paw; M M Kaback; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.

Authors:  R Navon; R L Proia
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

7.  Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments.

Authors:  S Akli; J Chelly; J M Lacorte; L Poenaru; A Kahn
Journal:  Genomics       Date:  1991-09       Impact factor: 5.736

  7 in total
  3 in total

1.  Clinical, biochemical and mutation profile in Indian patients with Sandhoff disease.

Authors:  Parag M Tamhankar; Mehul Mistri; Pratima Kondurkar; Daksha Sanghavi; Jayesh Sheth
Journal:  J Hum Genet       Date:  2015-11-19       Impact factor: 3.172

2.  Ptosis in late infantile Tay-Sachs disease.

Authors:  R K Marwaha; P Singh; A Trehan
Journal:  Indian J Pediatr       Date:  2001-05       Impact factor: 1.967

Review 3.  Pediatric neurodegenerative white matter processes: leukodystrophies and beyond.

Authors:  Jonathan A Phelan; Lisa H Lowe; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2008-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.